B
SRNE

Baird’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Baird’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		$3.29M Sell
284,132
-60,141
-17% -$696K 0.03% 428
2014
Q4 		$3.47M Buy
344,273
+2,153
+0.6% +$10.9K 0.04% 424
2014
Q3 		$1.55M Buy
342,120
+130,827
+62% +$703K 0.02% 527
2014
Q2 		$1.43M Buy
211,293
+142,670
+208% +$1.08M 0.02% 577
2014
Q1 		$880K Buy
+68,623
New +$759K 0.01% 668

Other funds holding SRNE

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.98B AUM 737.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return